832
J. R. Young et al. / Bioorg. Med. Chem. Lett. 12 (2002) 827–832
Kieczykowski, Robert Frankshun, Amanda Makar-
ewicz andJoseph Simeone for preparation of several
key intermediates.
5. For application of the Larock method, see: Walsh, T. F.;
Toupence, R. B.; Ujjainwalla, F.; Young, J. R.; Goulet, M. T.
Tetrahedron 2001, 57, 5233.
6. Fukuyama, T.; Cheung, M.; Jow, C.-K.; Hidai, Y.; Kan, T.
Tetrahedron Lett. 1997, 38, 5831.
7. Miller, R. B.; Frincke, J. M. J. Org. Chem. 1980, 45, 5312.
8. (a) Sanchez, J. P.; Rogowski, J. W. J. Heterocyclic Chem.
1987, 24, 215. (b) Hirose, T.; Mishio, S.; Matsumoto, J.-I.;
Minami, S. Chem. Pharm. Bull. 1982, 30, 2399.
9. Reuman, M.; Eissenstat, M. A. Tetrahedron Lett. 1994,
358, 8303.
10. (a) Louvet, P.; Pernot-Marino, I.; Luu-Duc, C.; Blanchet,
G. Eur. Med. Chem. 1993, 28, 71. (b) Denzel, T.; Hohn, H. J.
Heterocycl. Chem. 1977, 14, 813.
11. Ennis, B. C.; Holan, G.; Samuel, E. L. J. Chem. Soc. C
1967, 30.
12. Whitten, J. P.; Matthews, D. P.; McCarthy, J. R. J. Org.
Chem. 1986, 51, 1891.
13. Temple, C., Jr.; Smith, B. H., Jr.; Montgomery, J. A. J.
Org. Chem. 1973, 38, 1095.
14. Denyer, C. V.; Bunyan, H.; Loakes, D. M.; Tucker, J.;
Gillam, J. Tetrahedron 1995, 51, 5057.
15. Kikukawa, K.; Umekawa, H.; Matsuda, T. J. Organomet.
Chem. 1986, 311, 44.
16. Oh-e, T.; Miyaura, N.; Suzuki, A. J. Org. Chem. 1993, 58,
2201.
17. Okano, T.; Harada, N.; Kiji, J. Bull. Chem. Soc. Jpn.
1994, 67, 2329.
18. Stille, J. K.; Groh, B. L. J. Am. Chem. Soc. 1987, 109, 813.
19. Buckle, D. R.; Arch, J. R. S.; Edge, C.; Foster, K. A.;
Houge-Frydrych, S. S. V.; Pinto, I. L.; Smith, D. G.; Taylor,
J. F.; Taylor, S. G.; Tedder, J. M.; Webster, R. A. B. J. Med.
Chem. 1991, 34, 919.
20. Lee, H.; Harvey, R. G. J. Org. Chem. 1986, 51, 3502.
21. Varghese, J. P.; Sudalai, A.; Iyer, S. Synth. Commun. 1995,
25, 2267.
22. The effect of selectedcompounds on cytochrome P450 3A-
catalyzederythromycin N-demethylation, testosterone 6b-
hydroxylation and midazolam 10-hydroxylation was studied
after co-incubation at different concentrations (0.05–10 mM),
with an appropriate range of substrate concentrations: ery-
thromycin at 50–500 mM, testosterone at 20–1000 mM and
midazolam at 1–50 mM. The human liver microsomes in these
studies were mixtures of preparations from 5–10 subjects. The
incubations were carriedout at 37 ꢀC under linear conditions
for substrate turnover with respect to microsomal protein
concentration andincubation time. The microsomal protein
concentration usedwas 0.25 mg/mL for the miadzolam
hydroxylation, 0.5 mg/mL for the testosterone and 2 mg/mL
for the erythromycin assay. The possibility of time-dependent
inhibition was investigatedby pre-incubating compounsd
(0.1–50 mM) with human liver microsomes in the presence of
an NADPH-regenerating system for 0–30 min prior to the
addition of 250 mM testosterone. Extracts of the incubation
mixtures were analyzedby HPLC with UV detection (testos-
terone 6b-hydroxylation, midazolam 10-hydroxylation) or LC–
MS/MS (midazolam 10-hydroxylation and erythromycin N-
demethylation). The values for the apparent Km and Vmax
were estimatedby fitting the data to the Michaelis–Menten
equation, using non-linear regression.
References and Notes
1. (a) DeVita, R. J.; Hollings, D. D.; Goulet, M. T.; Wyvratt,
M. J.; Fisher, M. H.; Lo, J.-L.; Yang, Y. T.; Cheng, K.; Smith,
R. G. Bioorg. Med. Chem. Lett. 1999, 9, 2615. (b) DeVita,
R. J.; Goulet, M. T.; Wyvratt, M. J.; Fisher, M. H.; Lo, J.-L.;
Yang, Y. T.; Cheng, K.; Smith, R. G. Bioorg. Med. Chem.
Lett. 1999, 9, 2621. (c) Walsh, T. F.; Toupence, R. B.; Young,
J. R.; Huang, S. X.; Ujjainwalla, F.; DeVita, R. J.; Goulet,
M. T.; Wyvratt, M. J., Jr.; Fisher, M. H.; Lo, J.-L.; Ren, N.;
Yudkovitz, J. B.; Yang, Y. T.; Cheng, K.; Smith, R. G.
Bioorg. Med. Chem. Lett. 2000, 10, 443. (d) Young, J. R.;
Huang, S. X.; Chen, I.; Walsh, T. F.; DeVita, R. J.; Wyvratt,
M. J., Jr.; Goulet, M. T.; Ren, N.; Lo, J.-L.; Yang, Y. T.;
Yudkovitz, J. B.; Cheng, K.; Smith, R. G. Bioorg. Med. Chem.
Lett. 2000, 10, 1773. (e) DeVita, R. J.; Walsh, T. F.; Young,
J. R.; Jiang, J.; Ujjainwalla, F.; Toupence, R. B.; Parikh, M.;
Huang, S. X.; Fair, J. A.; Goulet, M. T.; Wyvratt, M. J., Jr.;
Lo, J.-L.; Ren, N.; Yudkovitz, J. B.; Yang, Y. T.; Cheng, K.;
Cui, J.; Mount, G.; Rohrer, S. P.; Schaeffer, J. M.; Rhodes, L.;
Drisko, J. E.; McGowan, E.; MacIntyre, D. E.; Vincent, S. H.;
Carlin, J. R.; Cameron, J.; Smith, R. G. J. Med. Chem. 2001,
44, 917.
2. (a) Chu, L.; Hutchins, J. E.; Weber, A. E.; Lo, J.-L.; Yang,
Y. T.; Cheng, K.; Smith, R. G.; Fisher, M. H.; Wyvratt, M. J.;
Goulet, M. T. Bioorg. Med. Chem. Lett. 2001, 11, 509. (b)
Chu, L.; Lo, J.-L.; Yang, Y. T.; Cheng, K.; Smith, R. G.;
Fisher, M. H.; Wyvratt, M. J.; Goulet, M. T. Bioorg. Med.
Chem. Lett. 2001, 11, 515. (c) Lin, P.; Marino, D.; Lo, J.-L.;
Yang, Y.-T.; Cheng, K.; Smith, R. G.; Fisher, M. H.; Wyv-
ratt, M. J.; Goulet, M. T. Bioorg. Med. Chem. Lett. 2001, 11,
1073. (d) Ashton, W. T.; Sisco, R. M.; Yang, Y. T.; Lo, J.-L.;
Yudkovitz, J. B.; Cheng, K.; Goulet, M. T. Bioorg. Med.
Chem. Lett. 2001, 11, 1723. (e) Ashton, W. T.; Sisco, R. M.;
Yang, Y. T.; Lo, J.-L.; Yudkovitz, J. B.; Gibbons, P. H.;
Mount, G. R.; Ren, R. N.; Butler, B. S.; Cheng, K.; Goulet,
M. T. Bioorg. Med. Chem. Lett. 2001, 11, 1727. (f) Lin, P.;
Parikh, M.; Lo, J.-L.; Yang, Y.-T.; Cheng, K.; Smith, R. G.;
Fisher, M. H.; Wyvratt, M. J.; Goulet, M. T. Bioorg. Med.
Chem. Lett. 2001, 11, 1077. (g) Simeone, J. P.; Bugianesi, R.
L.; Ponpipom, M. M.; Goulet, M. T.; Levorse, M. S.; Desai,
R. C. Tetrahedron Lett. Submittedfor publication. (h)
Simeone, J. P., Bugianesi, R. L. Unpublishedwork from
Merck Research Laboratories. (i) Ashton, W. T.; Sisco, R. M.;
Kieczykowski, G. R.; Yang, Y. T.; Yudkovitz, J. B.; Cui, J.;
Mount, G. R.; Ren, R. N.; Wu, T.-J.; Shen, X.; Lyons, K. A.;
Mao, A.-H.; Carlin, J. R.; Karanam, B. V.; Vincent, S. H.;
Cheng, K.; Goulet, M. T. Bioorg. Med. Chem. Lett. 2001, 11,
2597.
3. See ref 1c for details concerning the in vitro assays. The
0
IC50 s reportedherein are minimally an average of two titra-
tions.
4. For synthesis of the tryptamine core via a Fischer-indole
method, see ref 2g.